Boston Children's Hospital, MA, USA.
Syracuse University, NY, USA.
J Atten Disord. 2022 Oct;26(12):1622-1630. doi: 10.1177/10870547221092095. Epub 2022 Apr 25.
There is increased concern for malingering in ADHD evaluations due to presence of incentives such as accommodations and medications. Although several validity tests are available to classify malingering in non-ADHD populations, there is no test with proven effectiveness to detect feigned ADHD. This study investigated the ability of the MARS Symptom Validity Index 4 (MARS SV-index 4) and two published validity tests (the Word Memory Test [WMT] and Clinical Assessment of Attention Deficit-Adult [CAT-A] Infrequency scale) to detect malingered ADHD.
The participants consisted of 68 young adults, 34 with ADHD. Participants completed the MARS, CAT-A, and WMT validity measures.
The MARS SV index-4 demonstrated higher sensitivity rates for simulated malingering (61.8%) at close to optimal specificity (88.2%) compared to two published tests (which had sensitivity <42% at specificity >90%).
The MARS shows good ability to detect feigned ADHD and appears to be useful for adult ADHD assessments.
由于 ADHD 评估中存在诸如适应和药物治疗等激励措施,因此人们越来越担心出现装病行为。尽管有几种效度测试可用于对非 ADHD 人群进行装病分类,但尚无经过验证可有效检测出假装 ADHD 的测试。本研究旨在调查 MARS 症状效度指数 4 (MARS SV-index 4)和两项已发表的效度测试(单词记忆测试 [WMT]和成人注意力缺陷临床评估 [CAT-A]不频繁量表)检测假装 ADHD 的能力。
参与者包括 68 名年轻成年人,其中 34 名患有 ADHD。参与者完成了 MARS、CAT-A 和 WMT 效度测试。
与两项已发表的测试(特异性 >90%时敏感性 <42%)相比,MARS SV 指数-4 对模拟装病的敏感性更高(61.8%),而特异性接近最佳(88.2%)。
MARS 能够很好地检测出假装的 ADHD,似乎对成人 ADHD 评估有用。